文献速递妇科

激素受体状态与卵巢切除术在子宫平滑肌肉瘤中的作用

Hormone receptor status and the role of oophorectomy in uterine leiomyosarcoma.
PubMed 文献 · Gynecol Oncol · 2022-10-19

本研究回顾性分析了2013年1月至2018年1月间治疗的189例子宫平滑肌肉瘤患者,旨在描述卵巢切除术及雌激素/孕激素受体状态对临床结局和生存的影响。结果显示,卵巢切除术状态对无事件生存期或总生存期均无影响,雌激素/孕激素受体状态亦未独立与生存相关。

要点

  • 在189例患者中,94.7%以手术为主要治疗,28.5%保留卵巢。
  • 卵巢切除术状态与无事件生存期或总生存期无差异。
  • 雌激素/孕激素受体阳性率分别为41%和33%,但与生存无独立关联。

核心结论

  • 卵巢切除术未影响总生存期,尽管许多肿瘤为激素受体阳性。
  • 雌激素/孕激素受体状态未独立与生存相关,包括在子宫局限性疾病和接受卵巢切除术的亚组中。

研究设计与样本

  • 回顾性识别2013年1月至2018年1月间治疗的子宫平滑肌肉瘤女性患者,共纳入189例。
  • 收集临床数据,进行描述性统计,并使用Cox回归和Kaplan-Meier方法分析总生存期和无事件生存期的预测因素。

主要发现

  • 中位年龄53岁(范围20-84岁)。
  • 多数患者为IB期(58%)和3级(94%)肿瘤。
  • 病理分析中,雌激素受体和孕激素受体表达阳性率分别为41%和33%。
  • 大多数患者(179例,94.7%)以手术为主要治疗,其中51例(28.5%)保留卵巢。
  • 59.0%接受化疗,9.9%接受放疗;84.6%的患者出现复发,但按卵巢切除术状态分组,无事件生存期或总生存期无差异,包括在子宫局限性疾病患者中。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Uterine leiomyosarcoma (ULMS) is an aggressive malignancy for which hysterectomy is often the primary treatment approach. Due to the rarity of these tumors, the role of oophorectomy in the management of ULMS is not clearly established. This study aimed to describe the impact of oophorectomy and estrogen/progesterone (ER/PR) receptor status on clinical outcomes and survival. METHODS: Women with ULMS treated between 1/2013 and 1/2018 were retrospectively identified. Clinical data was collected; descriptive statistics were performed and predictors of overall survival (OS) and event free survival (EFS) were analyzed using Cox regression and Kaplan-Meier methodology. RESULTS: 189 patients were included. Median age was 53 years (20-84 years). The majority of patients had stage IB (58%) and grade 3 (94%) tumors. On pathologic analysis, ER/PR expression was positive in 41% and 33%, respectively. The majority of patients (179, 94.7%) underwent surgery as their primary treatment approach, of which 51 (28.5%) had ovarian conservation. 59.0% were treated with chemotherapy, while 9.9% received radiation therapy. 84.6% of patients experienced a recurrence, but there was no difference in EFS or OS by oophorectomy status, including among those with uterine confined disease. Additionally, ER/PR status was not independently associated with EFS/OS (p = 0.14, p = 0.07) nor did it impact survival among those with ovaries left in situ. CONCLUSIONS: Oophorectomy did not influence OS, even though many tumors were hormone receptor positive. ER/PR status was not independently associated with survival, including in the subset of women with uterine confined disease and those who had undergone oophorectomy.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Hinchcliff E, Rumpf J, Ratan R, et al. Hormone receptor status and the role of oophorectomy in uterine leiomyosarcoma. Gynecol Oncol. 2022. PMID: 36270831. doi:10.1016/j.ygyno.2022.09.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。